| NCT05480306 | Phase 2 Study of DKN-01 in Colorectal Cancer | COMPLETED | PHASE2 | 2022-08-30 | 2025-07-10 | 2025-07-10 |
| NCT04363801 | A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer | TERMINATED | PHASE2 | 2020-07-29 | 2025-03-31 | 2025-03-31 |
| NCT03861403 | A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors | TERMINATED | PHASE1 | 2019-05-20 | 2020-07-14 | 2020-07-14 |
| NCT03395080 | A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | COMPLETED | PHASE2 | 2018-03-05 | 2021-01-27 | 2020-09-09 |
| NCT02628574 | Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab | COMPLETED | PHASE1 | 2016-01 | 2020-07-14 | 2020-07-14 |
| NCT02375880 | Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder | COMPLETED | PHASE1 | 2015-06 | 2018-07 | 2018-07 |
| NCT02013154 | A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab | COMPLETED | PHASE1 | 2014-05-05 | 2021-01-11 | 2019-07-19 |
| NCT01711671 | A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | COMPLETED | PHASE1 | 2013-05 | 2015-07 | 2015-07 |
| NCT01457417 | A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-01 | 2013-12 | 2013-12 |
| NCT01239134 | Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors | COMPLETED | PHASE1 | 2010-10 | 2018-09 | 2018-09 |